[1] Cheng L, Albers P, Berney D M, et al. Testicular cancer[J]. Nat Rev Dis Primers, 2018, 4(1):29
[2] Daugaard G, Gundgaard M G, Mortensen M S, et al. Surveillance for stage I nonseminoma testicular cancer:outcomes and long-term follow-up in a population-based cohort[J]. J Clin Oncol, 2014, 32(34):3817
[3] Hofmann I, Thompson A, Sanderson C M, et al. The Arl4 family of small G proteins can recruit the cytohesin Arf6 exchange factors to the plasma membrane[J]. Curr Biol, 2007, 17(8):711
[4] Fujii S, Matsumoto S, Nojima S, et al. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and May represent a novel therapeutic target[J]. Oncogene, 2015, 34(37):4834
[5] Bergom C, Hauser A D, Rymaszewski A, et al. The tumor-suppressive small GTPase DiRas1 binds the noncanonical guanine nucleotide exchange factor SmgGDS and antagonizes SmgGDS interactions with oncogenic small GTPases[J]. J Biol Chem, 2016, 291(12):6534
[6] Ellis C A, Vos M D, Howell H, et al. Rig is a novel Ras-related protein and potential neural tumor suppressor[J]. Proc Natl Acad Sci U S A, 2002,99(15):9876
[7] Zhu Y H, Fu L, Chen L L, et al. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma[J]. Cancer Res, 2013, 73(7):2298
[8] Vasdev N, Moon A, Thorpe A C, et al. Classification, epidemiology and therapies for testicular germ cell tumours[J]. Int J Dev Biol, 2013, 57(2/4):133
[9] Almstrup K, Nielsen J E, Mlynarska O, et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells[J]. Br J Cancer, 2010, 103(8):1269
[10] Berney D M, Looijenga L H, Idrees M, et al. Germ cell neoplasia in situ(GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy[J]. Histopathology, 2016, 69(1):7
[11] Gillingham A K, Munro S.The small G proteins of the Arf family and their regulators[J]. Annu Rev Cell Dev Biol, 2007, 23(1):579
[12] Bhamidipati A, Lewis S A, Cowan N J. ADP ribosylation factor-like protein 2(Arl2)regulates the interaction of tubulin-folding cofactor D with native tubulin[J]. J Cell Biol, 2000, 149(5):1087
[13] Lu L, Tai G, Hong W. Autoantigen Golgin-97, an effector of Arl1 GTPase, participates in traffic from the endosome to the trans-Golgi network [J]. Mol Biol Cell, 2004, 15(10):4426
[14] Lin C Y, Huang P H, Liao W L, et al. ARL4,an ARF-like protein that is developmentally regulated and localized to nuclei and nucleoli[J]. J Biol Chem, 2000, 275(48):37815
[15] Wei S M, Xie C G, Abe Y, et al. ADP-ribosylation factor like 7(ARL7)interacts with alpha-tubulin and modulates intracellular vesicular transport[J]. Biochem Biophys Res Commun, 2009, 384(3):352
[16] Matsumoto S, Fujii S, Sato A, et al. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures[J]. EMBO J, 2014, 33(7):702
[17] Hu Q, Masuda T, Sato K, et al. Identification of ARL4C as a peritoneal dissemination-associated gene and its clinical significance in gastric cancer[J]. Ann Surg Oncol, 2018, 25(3):745